Amicus Therapeutics Inc (FOLD)
9.41
+0.10
(+1.07%)
USD |
NASDAQ |
Jan 03, 16:00
9.415
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Revenue (Annual): 399.36M for Dec. 31, 2023
Revenue (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Annual) Benchmarks
Tonix Pharmaceuticals Holding Corp | 7.768M |
Immuneering Corp | -- |
Halozyme Therapeutics Inc | 829.25M |
Alnylam Pharmaceuticals Inc | 1.828B |
Insmed Inc | 305.21M |